Familial Evaluation in Catecholaminergic Polymorphic Ventricular Tachycardia Disease Penetrance and Expression in Cardiac Ryanodine Receptor Mutation-Carrying Relatives

被引:128
|
作者
van der Werf, Christian [1 ]
Nederend, Ineke [1 ]
Hofman, Nynke [2 ]
van Geloven, Nan [3 ]
Ebink, Corne [4 ]
Frohn-Mulder, Ingrid M. E. [5 ]
Alings, A. Marco W. [6 ]
Bosker, Hans A. [2 ,7 ]
Bracke, Frank A. [8 ]
van den Heuvel, Freek [9 ]
Waalewijn, Reinier A. [12 ]
Bikker, Hennie
van Tintelen, J. Peter [10 ]
Bhuiyan, Zahurul A. [2 ,13 ]
van den Berg, Maarten P. [11 ]
Wilde, Arthur A. M. [1 ]
机构
[1] Univ Amsterdam, Dept Cardiol, Heart Failure Res Ctr, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Dept Clin Genet, NL-1105 AZ Amsterdam, Netherlands
[3] Univ Amsterdam, Acad Med Ctr, Clin Res Unit, NL-1105 AZ Amsterdam, Netherlands
[4] Maasstad Hosp, Dept Cardiol, Rotterdam, Netherlands
[5] Erasmus MC Sophia, Div Pediat Cardiol, Dept Pediat, Rotterdam, Netherlands
[6] Amphia Hosp, Dept Cardiol, Breda, Netherlands
[7] Rijnstate Hosp, Dept Cardiol, Arnhem, Netherlands
[8] Catharina Hosp, Dept Cardiol, Eindhoven, Netherlands
[9] Univ Groningen, Univ Med Ctr Groningen, Dept Pediat, Div Pediat Cardiol, NL-9700 AB Groningen, Netherlands
[10] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands
[11] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands
[12] Gelre Hosp, Dept Cardiol, Apeldoorn, Netherlands
[13] CHU Vaudois, Gen Med Serv, Lab Genet Mol, Lausanne, Switzerland
来源
关键词
catecholaminergic polymorphic ventricular tachycardia; death; sudden; genetics; ion channels; tachyarrhythmias; ARRHYTHMIA SYNDROMES; RELEASE CHANNEL; SUDDEN-DEATH; FOLLOW-UP; GENE; DYSFUNCTION; MECHANISM; SPECTRUM; FEATURES; CARRIERS;
D O I
10.1161/CIRCEP.112.970517
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Catecholaminergic polymorphic ventricular tachycardia (CPVT) is an inherited arrhythmia syndrome associated with mutations in the cardiac ryanodine receptor gene (RYR2) in the majority of patients. Previous studies of CPVT patients mainly involved probands, so current insight into disease penetrance, expression, genotype-phenotype correlations, and arrhythmic event rates in relatives carrying a RYR2 mutation is limited. Methods and Results-One-hundred sixteen relatives carrying a RYR2 mutation from 15 families who were identified by cascade screening of the RYR2 mutation causing CPVT in the proband were clinically characterized, including 61 relatives from 1 family. Fifty-four of 108 antiarrhythmic drug-free relatives (50%) had a CPVT phenotype at the first cardiological examination, including 27 (25%) with nonsustained ventricular tachycardia. Relatives carrying a RYR2 mutation in the C-terminal channel-forming domain showed an increased odds of nonsustained ventricular tachycardia (odds ratio, 4.1; 95% CI, 1.5-11.5; P=0.007, compared with N-terminal domain). Sinus bradycardia was observed in 19% of relatives, whereas other supraventricular dysrhythmias were present in 16%. Ninety-eight (most actively treated) relatives (84%) were followed up for a median of 4.7 years (range, 0.3-19.0 years). During follow-up, 2 asymptomatic relatives experienced exercise-induced syncope. One relative was not being treated, whereas the other was noncompliant. None of the 116 relatives died of CPVT during a 6.7-year follow-up (range, 1.4-20.9 years). Conclusions-Relatives carrying an RYR2 mutation show a marked phenotypic diversity. The vast majority do not have signs of supraventricular disease manifestations. Mutation location may be associated with severity of the phenotype. The arrhythmic event rate during follow-up was low. (Circ Arrhythm Electrophysiol. 2012;5:748-756.)
引用
收藏
页码:748 / 756
页数:9
相关论文
共 50 条
  • [21] Cardiac ryanodine receptor gene (hRyR2) mutation underlying catecholaminergic polymorphic ventricular tachycardia in a Chinese adolescent presenting with sudden cardiac arrest and cardiac syncope
    Mok, Ngai-Shing
    Lam, Ching-Wan
    Fong, Nai-Chung
    Hui, Yim-Wo
    Choi, Yuen- Choi
    Chan, Kwok-Yin
    CHINESE MEDICAL JOURNAL, 2006, 119 (24) : 2129 - 2133
  • [22] Cardiac ryanodine receptor gene(hRyR2) mutation underlying catecholaminergic polymorphic ventricular tachycardia in a Chinese adolescent presenting with sudden cardiac arrest and cardiac syncope
    NgaiShing Mok
    ChingWan Lam
    NaiChung Fong
    YimWo Hui
    YuenChoi Choi
    KwokYin Chan
    Chinese Medical Journal, 2006, (24) : 2129 - 2133
  • [23] Cardiac ryanodine receptor gene(hRyR2) mutation underlying catecholaminergic polymorphic ventricular tachycardia in a Chinese adolescent presenting with sudden cardiac arrest and cardiac syncope
    Ngai-Shing Mok
    Ching-Wan Lam
    Nai-Chung Fong
    Yim-Wo Hui
    Yuen-Choi Choi
    Kwok-Yin Chan
    中华医学杂志(英文版), 2006, (24) : 2129 - 2133
  • [24] Atypical form of catecholaminergic ventricular tachycardia due to a G14876A mutation in the cardiac ryanodine receptor gene
    Probst, V
    Allouis, M
    Schott, JJ
    Le Marec, H
    CIRCULATION, 2004, 110 (17) : 694 - 694
  • [25] A Mutation Associated with Catecholaminergic Polymorphic Ventricular Tachycardia in the Cardiac Ryanodine Receptor (RyR2-V2475F) Yields a Highly Arrhythmogenic Channel
    Benkusky, Nancy A.
    Weber, Craig
    Scherman, Joseph
    Jones, Manorama
    Powers, Pat
    Hacker, Timothy
    Valdivia, Hector H.
    BIOPHYSICAL JOURNAL, 2009, 96 (03) : 550A - 550A
  • [26] Ryanodine receptor-bound calmodulin is essential to protect against catecholaminergic polymorphic ventricular tachycardia
    Nakamura, Yoshihide
    Yamamoto, Takeshi
    Kobayashi, Shigeki
    Tamitani, Masaki
    Hamada, Yoriomi
    Fukui, Go
    Xu, Xiaojuan
    Nishimura, Shigehiko
    Kato, Takayoshi
    Uchinoumi, Hitoshi
    Oda, Tetsuro
    Okuda, Shinichi
    Yano, Masafumi
    JCI INSIGHT, 2019, 4 (11)
  • [27] Mutation-Linked, Defective Inter-Domain Interaction within the Cardiac Ryanodine Receptor as a Critical Cause of Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)
    Uchinoumi, Hitoshi
    Yano, Masafumi
    Suetomi, Takeshi
    Xu, Xiaojuan
    Ono, Makoto
    Tateishi, Hiroki
    Okuda, Shinichi
    Kobayashi, Shigeki
    Yamamoto, Takeshi
    Ikeda, Yasuhiro
    Ohkusa, Tomoko
    Matsuzaki, Masunori
    CIRCULATION, 2008, 118 (18) : S526 - S526
  • [28] Exon 3 Deletion of Ryanodine Receptor Causes Left Ventricular Noncompaction, Worsening Catecholaminergic Polymorphic Ventricular Tachycardia, and Sudden Cardiac Arrest
    Campbell, Matthew J.
    Czosek, Richard J.
    Hinton, Robert B.
    Miller, Erin M.
    AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2015, 167 (09) : 2197 - 2200
  • [29] A gain of function ryanodine receptor 2 mutation (R1760W-RyR2) in catecholaminergic polymorphic ventricular tachycardia
    Li, Siyuan
    Lv, Tingting
    Yang, Jing
    Li, Kun
    Yang, Ying
    Zhang, Ping
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2023, 50 (01) : 39 - 49
  • [30] Unusual clinical presentation in a family with catecholaminergic polymorphic ventricular tachycardia due to a G14876A ryanodine receptor gene mutation
    Allouis, M
    Probst, V
    Jaafar, P
    Schott, JJ
    Le Marec, H
    AMERICAN JOURNAL OF CARDIOLOGY, 2005, 95 (05): : 700 - 702